EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Safety and Clinical Efficacy of Prostatic Artery Embolization in Patients with Indwelling Urinary Catheter for Benign Hyperplasia—A Multicenter Study

Jules Pouchot, Amandine Crombé iD, Luc Burlet, Fadi Farah iD, Pierre Baseilhac, Arthur David iD, François Petitpierre iD, Rim Maaloum, Yann Le Bras, Gaele Pagnoux, Haytham Derbel iD, Hicham Kobeiter und 5 weitere

Diagnostics · 19.12.2024 · 14 (24) · 2864

DOI: 10.3390/diagnostics14242864 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 19.12.2024. Verfasst von Jules Pouchot und 16 weiteren Autor:innen. Beteiligte Einrichtung: Service de Radiologie et Imagerie Médicale de L'adulte, Centre Hospitalier Universitaire de Bordeaux, Place Amélie Raba Léon, 33076 Bordeaux, France. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: This multicentric study aimed to evaluate the efficacy and safety of prostatic artery embolization (PAE) to remove indwelling urinary catheter (IUC) in patients with symptomatic benign prostatic hyperplasia (BPH). Secondary objectives were to identify features associated with post-PAE catheter-free survival (PCFS).

Methods

All consecutive patients who underwent PAE for IUC related to BPH with a follow-up of at least 2 years (except for early death) in 6 French University Hospitals were retrospectively included. Clinical efficacy was defined as the removal of the IUC after PAE (through a trial without catheter [TWOC]) and evaluated at regular intervals. Chi-square tests, Wilcoxon tests and multivariable binary logistic regressions were utilized to investigate predictors of TWOC success. Univariable and multivariable Cox regressions were utilized to investigate predictors of PCFS in patients with TWOC success.

Results

140 men with IUC (median age: 82.5 years, interquartile range [IQR] = 73–88.2 years, range: 46–100) who underwent PAE between January 2017 and March 2021 were included. Initial successful catheter removal (TWOC success) following PAE occurred in 113/140 (80.7%) patients, and 3/140 (2.1%) patients encountered major complications. In patients with TWOC success, PCFS at 6 months, 1 year and 2 years were 87.5% (95%CI: 81.4–94.1), 84.4% (95%CI: 77.7–91.7) and 79% (71.3–87.4), respectively. No independent predictive factors for TWOC success and PCFS were identified.

Conclusions

PAE should be considered as a safe option with good clinical efficacy in the short and long term for elderly and inoperable patients with IUC due to symptomatic BPH.

Schlagwörter

Stichwörter der Autor:innen

prostate artery embolizationprostate benign hyperplasiasafetytreatment outcomeurinary catheter

Autor:innen und Institutionen

  • Service de Radiologie et Imagerie Médicale de L'adulte, Centre Hospitalier Universitaire de Bordeaux, Place Amélie Raba Léon, 33076 Bordeaux, France.
  • SARCOTARGET Team, Bordeaux Institute of Oncology (BRIC) INSERM U1312, 33076 Bordeaux, France.
  • Department of Medical Imaging, IPI Plateform, Nîmes University Hospital, University of Montpellier, Medical Imaging Group Nîmes, IMAGINE, 30029 Nîmes, France.
  • Department of Diagnostic and Interventional Medical Imaging, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Henri Mondor, Université Paris Est, 94000 Créteil, France.
  • Department of Uroradiology, Hospices Civils de Lyon, Hôpital Edouard Herriot, 69003 Lyon, France.
  • Department of Radiology, Nantes University Hospital, University of Medicine, 44000 Nantes, France.

ORCID-Profile: Amandine Crombé, Fadi Farah, Arthur David, François Petitpierre, Haytham Derbel, Julien Frandon, Clément Marcelin, Clément Klein, Eva Jambon

Zitieren

APA

Pouchot, J., Crombé, A., Burlet, L., Farah, F., Baseilhac, P., David, A., Petitpierre, F., Maaloum, R., Le Bras, Y., Pagnoux, G., Derbel, H., Kobeiter, H., Barral, M., Frandon, J., Marcelin, C., Klein, C., & Jambon, E. (2024). Safety and Clinical Efficacy of Prostatic Artery Embolization in Patients with Indwelling Urinary Catheter for Benign Hyperplasia—A Multicenter Study. Diagnostics, 14(24), 2864. https://doi.org/10.3390/diagnostics14242864

Vancouver

Pouchot J, Crombé A, Burlet L, Farah F, Baseilhac P, David A, et al. Safety and Clinical Efficacy of Prostatic Artery Embolization in Patients with Indwelling Urinary Catheter for Benign Hyperplasia—A Multicenter Study. Diagnostics. 2024;14(24):2864. doi:10.3390/diagnostics14242864

BibTeX
@article{Pouchot2024,
  author = {Pouchot, Jules and Crombé, Amandine and Burlet, Luc and Farah, Fadi and Baseilhac, Pierre and David, Arthur and Petitpierre, François and Maaloum, Rim and Le Bras, Yann and Pagnoux, Gaele and Derbel, Haytham and Kobeiter, Hicham and Barral, Matthias and Frandon, Julien and Marcelin, Clément and Klein, Clément and Jambon, Eva},
  title = {Safety and Clinical Efficacy of Prostatic Artery Embolization in Patients with Indwelling Urinary Catheter for Benign Hyperplasia—A Multicenter Study},
  journal = {Diagnostics},
  year = {2024},
  volume = {14},
  number = {24},
  pages = {2864},
  doi = {10.3390/diagnostics14242864}
}
Kostenlos starten →